Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
Owing to the advancement of technology combined with our deeper knowledge of human nature and diseases, we are able to move towards precision medicine, where patients are treated at the individual level in concordance with their genetic profiles. Lately, the integration of nanoparticles in biotechno...
Main Authors: | Neja Šamec, Alja Zottel, Alja Videtič Paska, Ivana Jovčevska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/3/490 |
Similar Items
-
Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
by: Alja Zottel, et al.
Published: (2020-07-01) -
Non-animal glioblastoma models for personalized treatment
by: Alja Zottel, et al.
Published: (2023-10-01) -
Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
by: Sara Colja, et al.
Published: (2023-05-01) -
Current Technologies for RNA-Directed Liquid Diagnostics
by: Maria Victoria Martinez-Dominguez, et al.
Published: (2021-10-01) -
High <i>FREM2</i> Gene and Protein Expression Are Associated with Favorable Prognosis of <i>IDH</i>-WT Glioblastomas
by: Ivana Jovčevska, et al.
Published: (2019-07-01)